con il contributo non condizionante di:
SESSION I – EFFICACY SO FAR
Chairman: C.H. Moskowitz
SESSION II – LECTURES ON HOT TOPICS
Chairman: P.L. Zinzani
SESSION III – NEXT STEPS: COMBINATIONS
Chairman: P. Armand
SESSION IV – NOVEL CHECKPOINT INHIBITORS
Chairman: B.D. Cheson
SESSION V – BISPECIFIC ANTIBODIES IN LYMPHOMAS
Chairman: C. Carlo-Stella
SESSION VI – LECTURES ON HOT TOPICS
Chairman: G. Lenz
SESSION VII – CLINICAL DATA IN LARGE B-CELL LYMPHOMAS
Chairmen: P. Corradini, M. Ruella
SESSION VIII – FUTURE INDICATIONS IN LARGE B-CELL LYPHOMAS
Chairmen: A.J.M. Ferreri, C. Tarella
SESSION IX – LECTURES ON HOT TOPICS
Chairman: F. Locatelli
SESSION X – OTHER LYMPHOMAS AND CLL
Chairman: N.H. Fowler
SESSION XI – THE NEXT STEPS...
C.A. Jacobson, S.J. Schuster